nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofarabine—RRM2—polycystic ovary syndrome	0.793	1	CbGaD
Clofarabine—RRM2—embryo—polycystic ovary syndrome	0.0034	0.0479	CbGeAlD
Clofarabine—POLA1—endometrium—polycystic ovary syndrome	0.00261	0.0367	CbGeAlD
Clofarabine—RRM2—endometrium—polycystic ovary syndrome	0.00249	0.0351	CbGeAlD
Clofarabine—POLA1—pituitary gland—polycystic ovary syndrome	0.00236	0.0332	CbGeAlD
Clofarabine—POLA1—adipose tissue—polycystic ovary syndrome	0.00235	0.0331	CbGeAlD
Clofarabine—RRM1—adrenal cortex—polycystic ovary syndrome	0.00232	0.0326	CbGeAlD
Clofarabine—RRM2—uterus—polycystic ovary syndrome	0.0023	0.0323	CbGeAlD
Clofarabine—RRM2—pituitary gland—polycystic ovary syndrome	0.00225	0.0317	CbGeAlD
Clofarabine—RRM2—adipose tissue—polycystic ovary syndrome	0.00225	0.0316	CbGeAlD
Clofarabine—DCK—embryo—polycystic ovary syndrome	0.0022	0.0309	CbGeAlD
Clofarabine—POLA1—adrenal gland—polycystic ovary syndrome	0.00211	0.0297	CbGeAlD
Clofarabine—RRM1—endometrium—polycystic ovary syndrome	0.00207	0.0291	CbGeAlD
Clofarabine—RRM2—adrenal gland—polycystic ovary syndrome	0.00201	0.0283	CbGeAlD
Clofarabine—POLA1—female gonad—polycystic ovary syndrome	0.00197	0.0277	CbGeAlD
Clofarabine—Respiratory distress—Metformin—polycystic ovary syndrome	0.00196	0.0617	CcSEcCtD
Clofarabine—POLA1—vagina—polycystic ovary syndrome	0.00195	0.0275	CbGeAlD
Clofarabine—RRM1—uterus—polycystic ovary syndrome	0.00191	0.0268	CbGeAlD
Clofarabine—RRM2—female gonad—polycystic ovary syndrome	0.00188	0.0264	CbGeAlD
Clofarabine—RRM1—pituitary gland—polycystic ovary syndrome	0.00187	0.0264	CbGeAlD
Clofarabine—RRM2—vagina—polycystic ovary syndrome	0.00187	0.0263	CbGeAlD
Clofarabine—RRM1—adipose tissue—polycystic ovary syndrome	0.00187	0.0262	CbGeAlD
Clofarabine—DCK—adrenal cortex—polycystic ovary syndrome	0.0018	0.0253	CbGeAlD
Clofarabine—RRM2—endocrine gland—polycystic ovary syndrome	0.00175	0.0246	CbGeAlD
Clofarabine—RRM1—adrenal gland—polycystic ovary syndrome	0.00167	0.0235	CbGeAlD
Clofarabine—Fungal infection—Metformin—polycystic ovary syndrome	0.00161	0.0508	CcSEcCtD
Clofarabine—DCK—endometrium—polycystic ovary syndrome	0.00161	0.0226	CbGeAlD
Clofarabine—RRM1—female gonad—polycystic ovary syndrome	0.00156	0.022	CbGeAlD
Clofarabine—RRM1—vagina—polycystic ovary syndrome	0.00155	0.0218	CbGeAlD
Clofarabine—DCK—uterus—polycystic ovary syndrome	0.00148	0.0208	CbGeAlD
Clofarabine—DCK—pituitary gland—polycystic ovary syndrome	0.00145	0.0205	CbGeAlD
Clofarabine—RRM1—endocrine gland—polycystic ovary syndrome	0.00145	0.0204	CbGeAlD
Clofarabine—DCK—adipose tissue—polycystic ovary syndrome	0.00145	0.0204	CbGeAlD
Clofarabine—Contusion—Metformin—polycystic ovary syndrome	0.00143	0.0449	CcSEcCtD
Clofarabine—RRM1—E2F transcription factor network—CCNE2—polycystic ovary syndrome	0.0013	0.0126	CbGpPWpGaD
Clofarabine—POLA1—E2F mediated regulation of DNA replication—CDC6—polycystic ovary syndrome	0.0013	0.0126	CbGpPWpGaD
Clofarabine—DCK—adrenal gland—polycystic ovary syndrome	0.0013	0.0183	CbGeAlD
Clofarabine—RRM1—E2F transcription factor network—CDC6—polycystic ovary syndrome	0.00122	0.0118	CbGpPWpGaD
Clofarabine—DCK—female gonad—polycystic ovary syndrome	0.00121	0.0171	CbGeAlD
Clofarabine—DCK—vagina—polycystic ovary syndrome	0.0012	0.0169	CbGeAlD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—CCNE2—polycystic ovary syndrome	0.00113	0.0109	CbGpPWpGaD
Clofarabine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—BCL11A—polycystic ovary syndrome	0.00113	0.0109	CbGpPWpGaD
Clofarabine—DCK—endocrine gland—polycystic ovary syndrome	0.00113	0.0159	CbGeAlD
Clofarabine—RRM2—E2F mediated regulation of DNA replication—CCNB1—polycystic ovary syndrome	0.00112	0.0109	CbGpPWpGaD
Clofarabine—POLA1—DNA Replication—CDC6—polycystic ovary syndrome	0.00107	0.0104	CbGpPWpGaD
Clofarabine—RRM2—E2F transcription factor network—CCNE2—polycystic ovary syndrome	0.00107	0.0104	CbGpPWpGaD
Clofarabine—POLA1—E2F mediated regulation of DNA replication—RRM2—polycystic ovary syndrome	0.00101	0.00983	CbGpPWpGaD
Clofarabine—RRM2—E2F transcription factor network—CDC6—polycystic ovary syndrome	0.00101	0.00975	CbGpPWpGaD
Clofarabine—ABCG2—adrenal cortex—polycystic ovary syndrome	0.001	0.0141	CbGeAlD
Clofarabine—RRM1—E2F transcription factor network—SULT2A1—polycystic ovary syndrome	0.000986	0.00955	CbGpPWpGaD
Clofarabine—RRM1—E2F transcription factor network—RRM2—polycystic ovary syndrome	0.000955	0.00925	CbGpPWpGaD
Clofarabine—Cladribine—RRM2—polycystic ovary syndrome	0.000937	1	CrCbGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—CCNE2—polycystic ovary syndrome	0.000931	0.00901	CbGpPWpGaD
Clofarabine—Lethargy—Metformin—polycystic ovary syndrome	0.000921	0.029	CcSEcCtD
Clofarabine—RRM1—Fluoropyrimidine Activity—MTHFR—polycystic ovary syndrome	0.000911	0.00882	CbGpPWpGaD
Clofarabine—RRM1—Nucleotide metabolism—RRM2—polycystic ovary syndrome	0.000905	0.00877	CbGpPWpGaD
Clofarabine—Pain in extremity—Metformin—polycystic ovary syndrome	0.000903	0.0284	CcSEcCtD
Clofarabine—ABCG2—endometrium—polycystic ovary syndrome	0.000897	0.0126	CbGeAlD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—CCNE2—polycystic ovary syndrome	0.00087	0.00842	CbGpPWpGaD
Clofarabine—Dehydration—Metformin—polycystic ovary syndrome	0.00084	0.0265	CcSEcCtD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—RRM2—polycystic ovary syndrome	0.00083	0.00803	CbGpPWpGaD
Clofarabine—ABCG2—uterus—polycystic ovary syndrome	0.000827	0.0116	CbGeAlD
Clofarabine—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.000825	0.026	CcSEcCtD
Clofarabine—RRM2—E2F transcription factor network—SULT2A1—polycystic ovary syndrome	0.000812	0.00786	CbGpPWpGaD
Clofarabine—ABCG2—pituitary gland—polycystic ovary syndrome	0.000812	0.0114	CbGeAlD
Clofarabine—ABCG2—adipose tissue—polycystic ovary syndrome	0.000808	0.0114	CbGeAlD
Clofarabine—Influenza—Metformin—polycystic ovary syndrome	0.00078	0.0246	CcSEcCtD
Clofarabine—RRM2—G1/S Transition—CCNE2—polycystic ovary syndrome	0.000777	0.00753	CbGpPWpGaD
Clofarabine—POLA1—E2F mediated regulation of DNA replication—CCNB1—polycystic ovary syndrome	0.000769	0.00745	CbGpPWpGaD
Clofarabine—Pancreatitis—Metformin—polycystic ovary syndrome	0.000765	0.0241	CcSEcCtD
Clofarabine—RRM2—Fluoropyrimidine Activity—MTHFR—polycystic ovary syndrome	0.00075	0.00727	CbGpPWpGaD
Clofarabine—POLA1—E2F transcription factor network—CCNE2—polycystic ovary syndrome	0.000733	0.00709	CbGpPWpGaD
Clofarabine—RRM2—G1/S Transition—CDC6—polycystic ovary syndrome	0.000731	0.00708	CbGpPWpGaD
Clofarabine—Neutropenia—Metformin—polycystic ovary syndrome	0.00073	0.023	CcSEcCtD
Clofarabine—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.000725	0.0229	CcSEcCtD
Clofarabine—ABCG2—adrenal gland—polycystic ovary syndrome	0.000725	0.0102	CbGeAlD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—TOP2A—polycystic ovary syndrome	0.000698	0.00676	CbGpPWpGaD
Clofarabine—DCK—Nucleotide metabolism—RRM2—polycystic ovary syndrome	0.000697	0.00675	CbGpPWpGaD
Clofarabine—Infestation NOS—Metformin—polycystic ovary syndrome	0.000696	0.0219	CcSEcCtD
Clofarabine—Infestation—Metformin—polycystic ovary syndrome	0.000696	0.0219	CcSEcCtD
Clofarabine—POLA1—E2F transcription factor network—CDC6—polycystic ovary syndrome	0.000689	0.00667	CbGpPWpGaD
Clofarabine—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.000682	0.0215	CcSEcCtD
Clofarabine—ABCG2—female gonad—polycystic ovary syndrome	0.000676	0.00951	CbGeAlD
Clofarabine—ABCG2—vagina—polycystic ovary syndrome	0.000672	0.00946	CbGeAlD
Clofarabine—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.000658	0.0207	CcSEcCtD
Clofarabine—RRM2—Mitotic G1-G1/S phases—CCNE2—polycystic ovary syndrome	0.000655	0.00634	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—RRM2—polycystic ovary syndrome	0.000638	0.00618	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—CCNE2—polycystic ovary syndrome	0.000637	0.00617	CbGpPWpGaD
Clofarabine—POLA1—DNA Replication Pre-Initiation—CDC6—polycystic ovary syndrome	0.000634	0.00614	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—CCNB1—polycystic ovary syndrome	0.000629	0.00609	CbGpPWpGaD
Clofarabine—RRM2—Mitotic G1-G1/S phases—CDC6—polycystic ovary syndrome	0.000616	0.00596	CbGpPWpGaD
Clofarabine—Oedema peripheral—Metformin—polycystic ovary syndrome	0.000615	0.0194	CcSEcCtD
Clofarabine—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.000614	0.0193	CcSEcCtD
Clofarabine—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00058	0.0183	CcSEcCtD
Clofarabine—Flushing—Metformin—polycystic ovary syndrome	0.00058	0.0183	CcSEcCtD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—TOP2A—polycystic ovary syndrome	0.000575	0.00557	CbGpPWpGaD
Clofarabine—Angiopathy—Metformin—polycystic ovary syndrome	0.000567	0.0179	CcSEcCtD
Clofarabine—Immune system disorder—Metformin—polycystic ovary syndrome	0.000564	0.0178	CcSEcCtD
Clofarabine—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.000563	0.0177	CcSEcCtD
Clofarabine—Chills—Metformin—polycystic ovary syndrome	0.00056	0.0177	CcSEcCtD
Clofarabine—POLA1—E2F transcription factor network—SULT2A1—polycystic ovary syndrome	0.000555	0.00538	CbGpPWpGaD
Clofarabine—ABCG2—Fluoropyrimidine Activity—RRM2—polycystic ovary syndrome	0.000555	0.00537	CbGpPWpGaD
Clofarabine—POLA1—Synthesis of DNA—CDC6—polycystic ovary syndrome	0.000553	0.00536	CbGpPWpGaD
Clofarabine—Erythema—Metformin—polycystic ovary syndrome	0.000544	0.0171	CcSEcCtD
Clofarabine—Malnutrition—Metformin—polycystic ovary syndrome	0.000544	0.0171	CcSEcCtD
Clofarabine—POLA1—E2F transcription factor network—RRM2—polycystic ovary syndrome	0.000538	0.00521	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—TOP2A—polycystic ovary syndrome	0.000537	0.0052	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	0.000537	0.0052	CbGpPWpGaD
Clofarabine—POLA1—G1/S Transition—CCNE2—polycystic ovary syndrome	0.000532	0.00515	CbGpPWpGaD
Clofarabine—POLA1—DNA Replication—CDC6—polycystic ovary syndrome	0.000519	0.00503	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—CCNB1—polycystic ovary syndrome	0.000518	0.00501	CbGpPWpGaD
Clofarabine—Tremor—Metformin—polycystic ovary syndrome	0.000509	0.0161	CcSEcCtD
Clofarabine—POLA1—G1/S Transition—CDC6—polycystic ovary syndrome	0.0005	0.00484	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—CCNB1—polycystic ovary syndrome	0.000484	0.00469	CbGpPWpGaD
Clofarabine—POLA1—S Phase—CCNE2—polycystic ovary syndrome	0.000483	0.00467	CbGpPWpGaD
Clofarabine—Hypertension—Metformin—polycystic ovary syndrome	0.000469	0.0148	CcSEcCtD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—RRM2—polycystic ovary syndrome	0.000467	0.00453	CbGpPWpGaD
Clofarabine—Myalgia—Metformin—polycystic ovary syndrome	0.000463	0.0146	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00046	0.0145	CcSEcCtD
Clofarabine—POLA1—S Phase—CDC6—polycystic ovary syndrome	0.000454	0.00439	CbGpPWpGaD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CCNE2—polycystic ovary syndrome	0.000448	0.00434	CbGpPWpGaD
Clofarabine—Oedema—Metformin—polycystic ovary syndrome	0.000444	0.014	CcSEcCtD
Clofarabine—Infection—Metformin—polycystic ovary syndrome	0.000441	0.0139	CcSEcCtD
Clofarabine—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000435	0.0137	CcSEcCtD
Clofarabine—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000434	0.0137	CcSEcCtD
Clofarabine—RRM2—G1/S Transition—CCNB1—polycystic ovary syndrome	0.000432	0.00419	CbGpPWpGaD
Clofarabine—Skin disorder—Metformin—polycystic ovary syndrome	0.000431	0.0136	CcSEcCtD
Clofarabine—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000429	0.0135	CcSEcCtD
Clofarabine—Anorexia—Metformin—polycystic ovary syndrome	0.000423	0.0133	CcSEcCtD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CDC6—polycystic ovary syndrome	0.000421	0.00408	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—RAB2A—polycystic ovary syndrome	0.000418	0.00405	CbGpPWpGaD
Clofarabine—Hypotension—Metformin—polycystic ovary syndrome	0.000415	0.0131	CcSEcCtD
Clofarabine—RRM2—Mitotic G1-G1/S phases—TOP2A—polycystic ovary syndrome	0.000405	0.00392	CbGpPWpGaD
Clofarabine—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000404	0.0127	CcSEcCtD
Clofarabine—Paraesthesia—Metformin—polycystic ovary syndrome	0.000398	0.0126	CcSEcCtD
Clofarabine—Dyspnoea—Metformin—polycystic ovary syndrome	0.000396	0.0125	CcSEcCtD
Clofarabine—Somnolence—Metformin—polycystic ovary syndrome	0.000394	0.0124	CcSEcCtD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—TOP2A—polycystic ovary syndrome	0.000393	0.00381	CbGpPWpGaD
Clofarabine—POLA1—G1/S Transition—RRM2—polycystic ovary syndrome	0.00039	0.00378	CbGpPWpGaD
Clofarabine—Decreased appetite—Metformin—polycystic ovary syndrome	0.000386	0.0122	CcSEcCtD
Clofarabine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—GAB1—polycystic ovary syndrome	0.000384	0.00372	CbGpPWpGaD
Clofarabine—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000383	0.0121	CcSEcCtD
Clofarabine—Fatigue—Metformin—polycystic ovary syndrome	0.000383	0.0121	CcSEcCtD
Clofarabine—POLA1—Mitotic M-M/G1 phases—RAB2A—polycystic ovary syndrome	0.000382	0.0037	CbGpPWpGaD
Clofarabine—ABCG2—Iron uptake and transport—TFRC—polycystic ovary syndrome	0.000378	0.00366	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—RAB2A—polycystic ovary syndrome	0.000374	0.00362	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.000372	0.00361	CbGpPWpGaD
Clofarabine—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000366	0.0115	CcSEcCtD
Clofarabine—RRM2—Mitotic G1-G1/S phases—CCNB1—polycystic ovary syndrome	0.000364	0.00353	CbGpPWpGaD
Clofarabine—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000363	0.0114	CcSEcCtD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—CCNB1—polycystic ovary syndrome	0.000354	0.00343	CbGpPWpGaD
Clofarabine—RRM1—E2F transcription factor network—SERPINE1—polycystic ovary syndrome	0.000353	0.00342	CbGpPWpGaD
Clofarabine—Abdominal pain—Metformin—polycystic ovary syndrome	0.000351	0.0111	CcSEcCtD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—IGFBP1—polycystic ovary syndrome	0.000338	0.00327	CbGpPWpGaD
Clofarabine—POLA1—Mitotic G1-G1/S phases—RRM2—polycystic ovary syndrome	0.000329	0.00318	CbGpPWpGaD
Clofarabine—Asthenia—Metformin—polycystic ovary syndrome	0.000318	0.01	CcSEcCtD
Clofarabine—Pruritus—Metformin—polycystic ovary syndrome	0.000314	0.00989	CcSEcCtD
Clofarabine—Diarrhoea—Metformin—polycystic ovary syndrome	0.000304	0.00957	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	0.000302	0.00293	CbGpPWpGaD
Clofarabine—POLA1—G1/S Transition—CCNB1—polycystic ovary syndrome	0.000296	0.00286	CbGpPWpGaD
Clofarabine—Dizziness—Metformin—polycystic ovary syndrome	0.000293	0.00925	CcSEcCtD
Clofarabine—RRM2—E2F transcription factor network—SERPINE1—polycystic ovary syndrome	0.00029	0.00281	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.000289	0.0028	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—RAB2A—polycystic ovary syndrome	0.000286	0.00277	CbGpPWpGaD
Clofarabine—Vomiting—Metformin—polycystic ovary syndrome	0.000282	0.00889	CcSEcCtD
Clofarabine—ABCG2—Fluoropyrimidine Activity—MTHFR—polycystic ovary syndrome	0.000281	0.00272	CbGpPWpGaD
Clofarabine—Rash—Metformin—polycystic ovary syndrome	0.00028	0.00882	CcSEcCtD
Clofarabine—Dermatitis—Metformin—polycystic ovary syndrome	0.00028	0.00881	CcSEcCtD
Clofarabine—Headache—Metformin—polycystic ovary syndrome	0.000278	0.00876	CcSEcCtD
Clofarabine—POLA1—Mitotic G1-G1/S phases—TOP2A—polycystic ovary syndrome	0.000277	0.00268	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—TFRC—polycystic ovary syndrome	0.000268	0.0026	CbGpPWpGaD
Clofarabine—Nausea—Metformin—polycystic ovary syndrome	0.000264	0.00831	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—RAB2A—polycystic ovary syndrome	0.000256	0.00248	CbGpPWpGaD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CCNB1—polycystic ovary syndrome	0.000249	0.00241	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000247	0.00239	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CCNE2—polycystic ovary syndrome	0.00024	0.00233	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—NMNAT3—polycystic ovary syndrome	0.000229	0.00222	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDC6—polycystic ovary syndrome	0.000226	0.00219	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CCNE2—polycystic ovary syndrome	0.000215	0.00208	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—LPCAT2—polycystic ovary syndrome	0.00021	0.00203	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—SUOX—polycystic ovary syndrome	0.00021	0.00203	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.00021	0.00203	CbGpPWpGaD
Clofarabine—POLA1—Mitotic M-M/G1 phases—CDC6—polycystic ovary syndrome	0.000207	0.002	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CDC6—polycystic ovary syndrome	0.000202	0.00196	CbGpPWpGaD
Clofarabine—ABCG2—HIF-2-alpha transcription factor network—SERPINE1—polycystic ovary syndrome	0.0002	0.00194	CbGpPWpGaD
Clofarabine—POLA1—E2F transcription factor network—SERPINE1—polycystic ovary syndrome	0.000199	0.00192	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—ISYNA1—polycystic ovary syndrome	0.000195	0.00189	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—NMNAT3—polycystic ovary syndrome	0.000189	0.00183	CbGpPWpGaD
Clofarabine—DCK—Metabolism—NMNAT3—polycystic ovary syndrome	0.000177	0.00171	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—LPCAT2—polycystic ovary syndrome	0.000173	0.00167	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—SUOX—polycystic ovary syndrome	0.000173	0.00167	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.000172	0.00167	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000169	0.00164	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—MAD2L1—polycystic ovary syndrome	0.000166	0.00161	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—AKR1C2—polycystic ovary syndrome	0.000166	0.00161	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—TEAD2—polycystic ovary syndrome	0.000166	0.00161	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CCNE2—polycystic ovary syndrome	0.000164	0.00159	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.000163	0.00158	CbGpPWpGaD
Clofarabine—DCK—Metabolism—LPCAT2—polycystic ovary syndrome	0.000161	0.00156	CbGpPWpGaD
Clofarabine—DCK—Metabolism—SUOX—polycystic ovary syndrome	0.000161	0.00156	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—ISYNA1—polycystic ovary syndrome	0.000161	0.00156	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—LMNA—polycystic ovary syndrome	0.000155	0.0015	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDC6—polycystic ovary syndrome	0.000154	0.0015	CbGpPWpGaD
Clofarabine—POLA1—Mitotic M-M/G1 phases—MAD2L1—polycystic ovary syndrome	0.000152	0.00147	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.00015	0.00145	CbGpPWpGaD
Clofarabine—DCK—Metabolism—ISYNA1—polycystic ovary syndrome	0.00015	0.00145	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—LEP—polycystic ovary syndrome	0.00015	0.00145	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—MAD2L1—polycystic ovary syndrome	0.000149	0.00144	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—TOP2A—polycystic ovary syndrome	0.000148	0.00144	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CCNE2—polycystic ovary syndrome	0.000147	0.00142	CbGpPWpGaD
Clofarabine—POLA1—Mitotic M-M/G1 phases—LMNA—polycystic ovary syndrome	0.000142	0.00137	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000139	0.00135	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000139	0.00135	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—LMNA—polycystic ovary syndrome	0.000138	0.00134	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CDC6—polycystic ovary syndrome	0.000138	0.00134	CbGpPWpGaD
Clofarabine—ABCG2—HIF-2-alpha transcription factor network—VEGFA—polycystic ovary syndrome	0.000138	0.00133	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—TEAD2—polycystic ovary syndrome	0.000137	0.00132	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—AKR1C2—polycystic ovary syndrome	0.000137	0.00132	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CCNB1—polycystic ovary syndrome	0.000134	0.00129	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—TOP2A—polycystic ovary syndrome	0.000133	0.00129	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000132	0.00128	CbGpPWpGaD
Clofarabine—DCK—Metabolism—TEAD2—polycystic ovary syndrome	0.000128	0.00124	CbGpPWpGaD
Clofarabine—DCK—Metabolism—AKR1C2—polycystic ovary syndrome	0.000128	0.00124	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—STAR—polycystic ovary syndrome	0.000126	0.00122	CbGpPWpGaD
Clofarabine—POLA1—Mitotic M-M/G1 phases—CCNB1—polycystic ovary syndrome	0.000122	0.00118	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000121	0.00117	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—RRM2—polycystic ovary syndrome	0.000121	0.00117	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CCNB1—polycystic ovary syndrome	0.000119	0.00116	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—SERPINE1—polycystic ovary syndrome	0.000118	0.00114	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PNPLA2—polycystic ovary syndrome	0.000114	0.00111	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—MAD2L1—polycystic ovary syndrome	0.000114	0.0011	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000112	0.00109	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—HMMR—polycystic ovary syndrome	0.000112	0.00109	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000109	0.00106	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000109	0.00105	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—RRM2—polycystic ovary syndrome	0.000108	0.00104	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PNPLA2—polycystic ovary syndrome	0.000107	0.00104	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000107	0.00104	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—LMNA—polycystic ovary syndrome	0.000106	0.00103	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—STAR—polycystic ovary syndrome	0.000104	0.001	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—MAD2L1—polycystic ovary syndrome	0.000102	0.000986	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—TOP2A—polycystic ovary syndrome	0.000101	0.000983	CbGpPWpGaD
Clofarabine—DCK—Metabolism—SRD5A1—polycystic ovary syndrome	0.000101	0.000982	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—LHB—polycystic ovary syndrome	9.75e-05	0.000944	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	9.69e-05	0.000938	CbGpPWpGaD
Clofarabine—DCK—Metabolism—STAR—polycystic ovary syndrome	9.67e-05	0.000937	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—HSD3B2—polycystic ovary syndrome	9.53e-05	0.000923	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—LMNA—polycystic ovary syndrome	9.47e-05	0.000917	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—HMMR—polycystic ovary syndrome	9.23e-05	0.000894	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—AKR1C1—polycystic ovary syndrome	9.23e-05	0.000894	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CCNB1—polycystic ovary syndrome	9.14e-05	0.000885	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—TOP2A—polycystic ovary syndrome	9.08e-05	0.000879	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—HSD3B1—polycystic ovary syndrome	8.8e-05	0.000853	CbGpPWpGaD
Clofarabine—DCK—Metabolism—HMMR—polycystic ovary syndrome	8.62e-05	0.000835	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—SULT2A1—polycystic ovary syndrome	8.49e-05	0.000822	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	8.46e-05	0.000819	CbGpPWpGaD
Clofarabine—DCK—Metabolism—HSD3B1—polycystic ovary syndrome	8.23e-05	0.000797	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—RRM2—polycystic ovary syndrome	8.22e-05	0.000797	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CCNB1—polycystic ovary syndrome	8.17e-05	0.000791	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—polycystic ovary syndrome	8.1e-05	0.000784	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—LHB—polycystic ovary syndrome	8.03e-05	0.000777	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—YAP1—polycystic ovary syndrome	7.93e-05	0.000768	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—HSD3B2—polycystic ovary syndrome	7.85e-05	0.00076	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—NAMPT—polycystic ovary syndrome	7.62e-05	0.000738	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—AKR1C1—polycystic ovary syndrome	7.6e-05	0.000736	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—CYP11A1—polycystic ovary syndrome	7.52e-05	0.000728	CbGpPWpGaD
Clofarabine—DCK—Metabolism—LHB—polycystic ovary syndrome	7.5e-05	0.000726	CbGpPWpGaD
Clofarabine—DCK—Metabolism—HSD3B2—polycystic ovary syndrome	7.33e-05	0.00071	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—AKR1C3—polycystic ovary syndrome	7.1e-05	0.000688	CbGpPWpGaD
Clofarabine—DCK—Metabolism—AKR1C1—polycystic ovary syndrome	7.1e-05	0.000688	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—NMNAT3—polycystic ovary syndrome	7.07e-05	0.000684	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—SULT2A1—polycystic ovary syndrome	6.99e-05	0.000677	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—CYP17A1—polycystic ovary syndrome	6.99e-05	0.000677	CbGpPWpGaD
Clofarabine—DCK—Metabolism—SULT2A1—polycystic ovary syndrome	6.53e-05	0.000633	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—YAP1—polycystic ovary syndrome	6.53e-05	0.000632	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—SUOX—polycystic ovary syndrome	6.46e-05	0.000626	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—LPCAT2—polycystic ovary syndrome	6.46e-05	0.000626	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	6.33e-05	0.000613	CbGpPWpGaD
Clofarabine—DCK—Metabolism—RRM2—polycystic ovary syndrome	6.33e-05	0.000613	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—NAMPT—polycystic ovary syndrome	6.27e-05	0.000607	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CYP11A1—polycystic ovary syndrome	6.19e-05	0.0006	CbGpPWpGaD
Clofarabine—DCK—Metabolism—YAP1—polycystic ovary syndrome	6.1e-05	0.000591	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—TH—polycystic ovary syndrome	6.05e-05	0.000586	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ISYNA1—polycystic ovary syndrome	6.01e-05	0.000582	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—SLC2A4—polycystic ovary syndrome	5.89e-05	0.00057	CbGpPWpGaD
Clofarabine—DCK—Metabolism—NAMPT—polycystic ovary syndrome	5.86e-05	0.000568	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—AKR1C3—polycystic ovary syndrome	5.85e-05	0.000567	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CYP11A1—polycystic ovary syndrome	5.79e-05	0.000561	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CYP17A1—polycystic ovary syndrome	5.76e-05	0.000558	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—CYP19A1—polycystic ovary syndrome	5.53e-05	0.000536	CbGpPWpGaD
Clofarabine—DCK—Metabolism—AKR1C3—polycystic ovary syndrome	5.47e-05	0.000529	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CYP17A1—polycystic ovary syndrome	5.38e-05	0.000521	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—TEAD2—polycystic ovary syndrome	5.11e-05	0.000495	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—AKR1C2—polycystic ovary syndrome	5.11e-05	0.000495	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—TH—polycystic ovary syndrome	4.98e-05	0.000483	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—GNAS—polycystic ovary syndrome	4.94e-05	0.000478	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—SLC2A4—polycystic ovary syndrome	4.85e-05	0.000469	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—NCOR1—polycystic ovary syndrome	4.71e-05	0.000456	CbGpPWpGaD
Clofarabine—DCK—Metabolism—TH—polycystic ovary syndrome	4.66e-05	0.000451	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CYP19A1—polycystic ovary syndrome	4.56e-05	0.000441	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	4.55e-05	0.000441	CbGpPWpGaD
Clofarabine—DCK—Metabolism—SLC2A4—polycystic ovary syndrome	4.53e-05	0.000439	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—CYP1A1—polycystic ovary syndrome	4.46e-05	0.000432	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PNPLA2—polycystic ovary syndrome	4.28e-05	0.000415	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CYP19A1—polycystic ovary syndrome	4.26e-05	0.000412	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	4.23e-05	0.00041	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—MTHFR—polycystic ovary syndrome	4.16e-05	0.000403	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—GNAS—polycystic ovary syndrome	4.07e-05	0.000394	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—SRD5A1—polycystic ovary syndrome	4.06e-05	0.000393	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—NCOR1—polycystic ovary syndrome	3.87e-05	0.000375	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—STAR—polycystic ovary syndrome	3.87e-05	0.000375	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	3.87e-05	0.000375	CbGpPWpGaD
Clofarabine—DCK—Metabolism—GNAS—polycystic ovary syndrome	3.8e-05	0.000368	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CYP1A1—polycystic ovary syndrome	3.67e-05	0.000356	CbGpPWpGaD
Clofarabine—DCK—Metabolism—NCOR1—polycystic ovary syndrome	3.62e-05	0.000351	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—HMMR—polycystic ovary syndrome	3.45e-05	0.000334	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CYP1A1—polycystic ovary syndrome	3.43e-05	0.000332	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—MTHFR—polycystic ovary syndrome	3.42e-05	0.000332	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PPARG—polycystic ovary syndrome	3.37e-05	0.000327	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—POMC—polycystic ovary syndrome	3.33e-05	0.000322	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—INS—polycystic ovary syndrome	3.31e-05	0.00032	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—HSD3B1—polycystic ovary syndrome	3.29e-05	0.000319	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	3.25e-05	0.000315	CbGpPWpGaD
Clofarabine—DCK—Metabolism—MTHFR—polycystic ovary syndrome	3.2e-05	0.00031	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—LHB—polycystic ovary syndrome	3e-05	0.000291	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—HSD3B2—polycystic ovary syndrome	2.93e-05	0.000284	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—AKR1C1—polycystic ovary syndrome	2.84e-05	0.000275	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PPARG—polycystic ovary syndrome	2.78e-05	0.000269	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—POMC—polycystic ovary syndrome	2.74e-05	0.000265	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—INS—polycystic ovary syndrome	2.72e-05	0.000264	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—SULT2A1—polycystic ovary syndrome	2.62e-05	0.000253	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PPARG—polycystic ovary syndrome	2.6e-05	0.000251	CbGpPWpGaD
Clofarabine—DCK—Metabolism—POMC—polycystic ovary syndrome	2.56e-05	0.000248	CbGpPWpGaD
Clofarabine—DCK—Metabolism—INS—polycystic ovary syndrome	2.55e-05	0.000246	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—RRM2—polycystic ovary syndrome	2.53e-05	0.000245	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—YAP1—polycystic ovary syndrome	2.44e-05	0.000236	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—NAMPT—polycystic ovary syndrome	2.35e-05	0.000227	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CYP11A1—polycystic ovary syndrome	2.32e-05	0.000224	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—AKR1C3—polycystic ovary syndrome	2.19e-05	0.000212	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CYP17A1—polycystic ovary syndrome	2.15e-05	0.000209	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—TH—polycystic ovary syndrome	1.86e-05	0.00018	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—SLC2A4—polycystic ovary syndrome	1.81e-05	0.000176	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CYP19A1—polycystic ovary syndrome	1.7e-05	0.000165	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GNAS—polycystic ovary syndrome	1.52e-05	0.000147	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—NCOR1—polycystic ovary syndrome	1.45e-05	0.00014	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CYP1A1—polycystic ovary syndrome	1.37e-05	0.000133	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—MTHFR—polycystic ovary syndrome	1.28e-05	0.000124	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PPARG—polycystic ovary syndrome	1.04e-05	0.000101	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—POMC—polycystic ovary syndrome	1.02e-05	9.92e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—INS—polycystic ovary syndrome	1.02e-05	9.86e-05	CbGpPWpGaD
